Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Expands By 332.2%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totaling 1,167 shares, a growth of 332.2% from the November 30th total of 270 shares. Based on an average daily volume of 27,709 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 27,709 shares, the days-to-cover ratio is presently 0.0 days.

CSPC Pharmaceutical Group Price Performance

Shares of OTCMKTS CSPCY opened at C$4.41 on Thursday. The stock’s 50-day moving average is C$4.02 and its 200 day moving average is C$4.52. CSPC Pharmaceutical Group has a 1-year low of C$2.15 and a 1-year high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.